Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Citadel Group Major Shareholding Notification 2020

May 7, 2020

10454_mrq_2020-05-07_94ce39cd-aa42-4637-b8ae-7c169fe48a8d.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3012M

Citadel Group

07 May 2020

Ap 19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.         KEY INFORMATION

Name of person dealing (Note 1)

Citadel Group

Company dealt in

ALLERGAN PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BY9D5467

Date of dealing

06 May, 2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security

dealt in (Note 3)

Long Short
Common Stock  ISIN  IE00BY9D5467 Number        (%) Number      (%)
(1) Relevant securities 3,059,923 (0.93%) 1,546 (0.00%)
(2) Derivatives (other than options) 3,465,201 (1.05%) 0 (0.00%)
(3) Options and agreements to purchase/sell 0 (0.00%) 0 (0.00%)
Total 6,525,124(1.98%) 1,546 (0.00%)

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Long Short
Number        (%) Number      (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap 20

1.         DEALINGS (Note 4)

(a)        Purchases and sales

Purchase/sale

Common Stock ISIN IE00BY9D5467
Number of securities Price per unit (Note 5)
a buy 429 193.89  USD
a buy 200 195.53  USD
a buy 27 195.55  USD
a sell -429 193.89  USD
a sell -227 195.5324  USD
Purchase 1,970 193.8899999  USD
Purchase 429 193.89  USD
Purchase 173 194.90450867  USD
Purchase 28 194.94  USD
Purchase 163 195.08687117  USD
Purchase 517 195.19123791  USD
Purchase 6 195.21  USD
Purchase 304 195.36065789  USD
Purchase 100 195.48  USD
Purchase 384 195.5165625  USD
Purchase 349 195.53570201  USD
Purchase 264 195.5419697  USD
Purchase 148 195.54594595  USD
Purchase 175 195.56697143  USD
Purchase 24 195.60416667  USD
Purchase 84 195.66845238  USD
Purchase 26 195.74269231  USD
Purchase 617 195.76659643  USD
Purchase 4 195.86  USD
Purchase 26 195.88538462  USD
Sale -225 193.8899999  USD
Sale -15 194.08  USD
Sale -8 194.1  USD
Sale -63 194.10793651  USD
Sale -167 194.25952096  USD
Sale -162 194.39895062  USD
Sale -6 194.44  USD
Sale -17 194.49176471  USD
Sale -63 194.65  USD
Sale -104 194.66  USD
Sale -20 194.67  USD
Sale -20 194.675  USD
Sale -4 194.68  USD
Sale -8 194.69  USD
Sale -270 194.79562963  USD
Sale -175 194.81714286  USD
Sale -33 194.91121212  USD
Sale -212 195.14867925  USD
Sale -862 195.27926914  USD
Sale -120 195.31083333  USD
Sale -110 195.42336364  USD
Sale -200 195.76  USD
Sale -10 195.84  USD
Sale -18 196.17888889  USD
Sale -6 196.25  USD

(b)        Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

 ISIN
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c)        Options transactions in respect of existing relevant securities

(i)         Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing,

varying etc.
Number of securities to which the option relates (Note 7) Exercise price Type,

e.g. American, European etc.
Expiry date Option money paid/ received per unit

(Note 5)

(ii)        Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit

(Note 5)

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

      (if applicable) (Note 5)

Ap 21

2.         OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None

Is a Supplemental Form 8 attached? (Note 9)

NO

Date of disclosure: 07 May, 2020
Contact name: Katie Bonds
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ISEBBGDUXDGDGGR